Five commercial peptides, namely, reduced glutathione (GSH), oxidized glutathione (GSSG),carnosine, homocarnosine,
and anserine, were used to test angiotensin converting enzyme inhibitory(ACEI) activities using
N-[3-(2-furyl)acryloyl]-Phe-Gly-Gly (FAPGG) as a substrate. All of these peptidesshowed dose-dependent ACEI activities. Using 50% inhibition (IC
50) of captopril as 0.00781
![](/images/entities/mgr.gif)
M forthe reference, the IC
50 values of GSH, carnosine, homocarnosine,
and anserine were determined tobe 32.4
![](/images/entities/mgr.gif)
M, 5.216 mM, 6.147 mM,
and 6.967 mM, respectively. GSH or carnosine showed mixednoncompetitive inhibition against ACE. When 0.0164 mM GSH or 0.4098 mM carnosine was added,the apparent inhibition constant (
Ki) was 49.7
![](/images/entities/mgr.gif)
M or 3.899 mM, respectively. Commercial glutathione-Sepharose 4 fast flow, GSH-coupled CNBr-activated
and GSH-coupled EAH-activated Sepharosegels were used for ACE purification. Commercial ACE could be adsorbed only by EAH-coupled GSHgels
and eluted off the gels by increasing salt concentrations. These EAH-coupled GSH gels mightbe developed as affinity aids for ACE purification.Keywords: Angiotensin converting enzyme (ACE); glutathione;
N-[3-(2-furyl)acryloyl]-Phe-Gly-Gly(FAPGG); peptide; EAH-activated gel